uniQure
QURE
#5325
Rank
ยฃ1.19 B
Marketcap
ยฃ17.29
Share price
-6.57%
Change (1 day)
-33.75%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of June 2026 : ยฃ0.60 Billion

According to uniQure's latest financial reports the company has ยฃ0.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ0.46 B57.84%
2024-12-31ยฃ0.29 B-39.62%
2023-12-31ยฃ0.48 B66.29%
2022-12-31ยฃ0.29 B-29.23%
2021-12-31ยฃ0.41 B129.33%
2020-12-31ยฃ0.17 B-37.63%
2019-12-31ยฃ0.28 B55.69%
2018-12-31ยฃ0.18 B56.93%
2017-12-31ยฃ0.11 B9.82%
2016-12-31ยฃ0.10 B-28.2%
2015-12-31ยฃ0.14 B259.79%
2014-12-31ยฃ41.56 M108.54%
2013-12-31ยฃ19.93 M9162.41%
2012-12-31ยฃ0.21 M-76.54%
2011-12-31ยฃ0.91 M-94.04%
2010-12-31ยฃ15.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
ยฃ10.42 B 1,626.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.40 B 794.38%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
ยฃ20.55 M-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
ยฃ58.67 M-90.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.65 B 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
ยฃ1.26 B 109.40%๐Ÿ‡บ๐Ÿ‡ธ USA